Related Experiment Video
Updated: Feb 16, 2026

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Species distribution, sequence types and antimicrobial resistance of Acinetobacter spp. from cystic fibrosis patients
G A Rocha1, D F Lima1, E R Rodrigues1
1Departamento de Microbiologia,Imunologia e Parasitologia,Universidade do Estado do Rio de Janeiro,Rio de Janeiro, RJ,Brazil.
Abstract:
Acinetobacter spp. are important healthcare pathogens, being closely linked to antibiotic resistance and outbreaks worldwide. Although such species are rarely observed in patients with cystic fibrosis (CF), we describe the characteristics of 53 strains of Acinetobacter spp. isolated from the sputum of 39 Brazilian patients with CF. The species distribution was A. baumannii (n = 29), A. pittii (n = 13), A. nosocomialis (n = 8), A. seifertii (n = 1), A. soli (n = 1) and A. variabilis (n = 1) determined by partial rpoB gene sequencing. Sixteen strains (10 A. baumannii, 3 A. pittii and 3 A. nosocomialis) were multidrug-resistant (MDR) by disk diffusion test (30%) and eight MDR carbapenem-resistant A. baumannii strains harboured the bla OXA-23-like oxacillinase gene. Thirty-three sequence types (STs) were identified by multilocus sequence typing of which eight were novel (A. baumannii: 843, 844, 845, 847, 848; A. pitti: 643; A. nosocomialis: 862 and A. seifertii: 846); six STs (2 A. baumannii, 3 A. pittii and 1 A. nosocomialis) were found in more than one patient. Four strains of A. baumannii were assigned to two common clonal complexes (CCs), namely, CC1 (ST1, ST20 and ST160), and CC79 (ST79). This study underlines the extensive species diversity of Acinetobacter spp. strains in CF lung infections which may present difficulties for therapy due to significant antimicrobial resistance.
Insights
Acinetobacter species were identified in cystic fibrosis (CF) patients, revealing significant diversity and multidrug resistance. This highlights challenges in treating CF lung infections with these opportunistic pathogens.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Genomics
Background:
- Acinetobacter species are significant healthcare-associated pathogens.
- These bacteria are increasingly linked to antibiotic resistance and global outbreaks.
- Their presence in cystic fibrosis (CF) patients is uncommon.
Purpose of the Study:
- To characterize Acinetobacter species found in Brazilian cystic fibrosis patients.
- To investigate the antimicrobial resistance profiles and genetic diversity of these isolates.
Main Methods:
- Isolation and identification of Acinetobacter species from patient sputum samples.
- Partial rpoB gene sequencing for species identification.
- Multidrug resistance (MDR) assessment using disk diffusion tests.
- Multilocus sequence typing (MLST) for genotypic diversity analysis.
Main Results:
- Fifty-three Acinetobacter strains were identified from 39 CF patients, representing diverse species including A. baumannii, A. pittii, and A. nosocomialis.
- Sixteen strains (30%) exhibited multidrug resistance (MDR).
- Eight MDR carbapenem-resistant A. baumannii strains carried the bla OXA-23-like gene.
- Thirty-three distinct sequence types (STs) were identified, with eight novel STs and several STs found in multiple patients, indicating potential transmission.
Conclusions:
- This study reveals substantial species diversity of Acinetobacter in CF lung infections.
- The high prevalence of antimicrobial resistance, including carbapenem resistance, poses significant therapeutic challenges.
- Further research is needed to understand the clinical implications and transmission dynamics of Acinetobacter in CF patients.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
07:25Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Multi-species Conserved Sequences
Although the genome of each species varies greatly from each other, a few sequences are highly conserved. Such conserved...
Data: Types and Distribution
Distributions in...
Pharmacokinetics in Pediatric Patients: Drug Distribution
What is a Species?